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Intracranial hypertension represents the 
increase in the intracranial pressure (ICP) 
due to disorders of the regulating 
mechanisms for intracranial pressure. It is 
caused by the intrinsic changes in the 
volumes of the intracranial compartments: 
brain parenchyma, cerebrospinal fluid and 
blood content, and/or by adding a 
pathological volume (extrinsic – tumor, 
haematoma, cerebral abscess, etc.).   
At first, the increase in the intracranial 
pressure is caused by the modification of 
the volume-pressure relations in correlation 
with time (the speed of occurrence and the 
duration of changes), which is induced by 
various etiologies; afterwards, the 
intracranial hypertension generates physio-
pathological disorders which cause specific 
modifications to the endocranial structures, 
and, therefore, the subsequent ICP increase 
is accompanied by its own symptomatology.   
In relation to its causal mechanism, the 
intracranial hypertension is and it may 
remain a symptom (increased intracranial 
pressure), or it evolves as a syndrome 
(increased intracranial pressure associated 
with other signs and symptoms). There are 
intracranial pressure values that are 
considered to be at the normal limit or 
moderately increased values, which do not 
induce evolutionary physio-pathological 
mechanisms by themselves. The 
subsequent evolution of the intracranial 
hypertension as a syndrome results from 
the very transformation of the initial ICP 
increase into a pathogenic mechanism and 
from the progression of the characteristic 
symptoms, whose intensity may exceed 
even the symptomatology of the initial 
illness.  
Depending on the etiology and on the 
pathogenic mechanism that generates the 
disorder in the volume-intracranial pressure 
relation, and based on the variation of the 
intracranial pressure in time, there is now 
an etiopathogenic classification of the 
intracranial hypertension, which includes 
both the etiopathogenic mechanisms and 
the clinical data (Iencean 2001, revised in 
2003). Many of the previous observations 
and findings of other authors have foreseen 
this systematization.   
1. Parenchymatous intracranial hypertension  
It occurs in the expanding intracranial 
processes (cerebral tumors, intracranial 
haematoma, cerebral abscesses, etc.), in the 
traumatic cerebral edema, in the cerebral 
ischemia with hypotoxic cerebral edema, in 
general intoxications with neurotoxins 
(endogenous or exogenous), etc. The 
primary cerebral etiology is known and it 
generates modifications of the intracranial 
volume; the cerebral edema occurs 
afterwards, and it evolves in parallel to the 
increase in the ICP. The parenchymatous 








intrinsic cerebral etiology and of the 
primary modifications in the intracranial 
volume (expansive, compressive, hypotoxic 
or traumatic cerebral edema). The 
parenchymatous intracranial hypertension 
may have a complete evolution to its acute 
form with a brain stem ischemia or cerebral 
hernia.  
2. Intracranial hypertension due to disorders 
of the cerebrospinal fluid dynamics   
The dynamics of the cerebrospinal fluid 
includes the circulation of the cerebrospinal 
fluid at the time of its creation at the level 
of the choroid plexuses, and until its 
passage into the venous circulation.  
The dynamic disorders of the 
cerebrospinal fluid may be:  
- circulation disorders of the 
cerebrospinal fluid from its creation until 
resorption, and   
- disorders in the passage of the 
cerebrospinal fluid in the venous drainage 
system (resorption).  
The circulation disorders of the 
cerebrospinal fluid are produced when 
there is an obstacle in the fluid itinerary 
(ventricular system, magna cistern, basal 
cisterns) due to the existence of a 
ventricular or para-ventricular tumor, intra-
ventricular hemorrhage, or obstruction of 
various causes of the Sylvian aqueduct. A 
dilatation of the segments of the ventricular 
system occurs, those that are supra-adjacent 
to the obstruction, while the clinical chart 
and the evolution are related to the 
obstructive internal hydrocephaly.  
The resorption disorders of the 
cerebrospinal fluid occur on account of the 
lesions of the anatomic structures that 
provide the passage of the cerebrospinal 
fluid from the sub-arachnoid spaces into 
the venous drainage system in acute 
meningitis, in sub-arachnoid hemorrhage, 
in meningitis carcinomatosis, in sarcoidosis 
chronic meningitis, etc. A thickening of the 
leptomeninx occurs, blocking the Pachioni 
arachnoid corpuscles, and decreasing the 
absorption of the cerebrospinal fluid. The 
cerebrospinal fluid accumulates in the sub-
arachnoid spaces and in the ventricular 
system, leading to a communicating 
hydrocephaly, with a peri-ventricular 
hydrocephalic cerebral edema and with an 
intracranial hypertension syndrome, which 
is usually a sub-acute one (called the 
meninx intracranial hypertension). The 
clinical chart and the increase in the 
intracranial pressure resemble the 
intracranial hypertension syndrome in cases 
of cerebrospinal fluid circulation 
obstruction.  
3. Vascular intracranial hypertension   
The ICP increase is caused by disorders 
of the sanguine, cerebral or extra-cerebral 
circulation. The increased volume of the 
cerebral parenchyma in vascular ICH is 
produced by a cerebral edema or by an 
increase in the cerebral sanguine volume 
(“congestive brain”). The cerebral edema 
and/or the congestive cerebral parenchyma 
will lead to an increased intracranial 
pressure. The increase in the cerebral 
sanguine volume occurs when there is an 
increased intracranial arterial sanguine 
supply or a decreased blockage of the 
venous drainage. When the venous drainage 
is reduced, there is also a decrease in the 
resorption of the cerebrospinal fluid. The 
“congestive brain” aspect is caused by the 
increase in the intra-cerebral sanguine 
volume, and the volume-intracranial 
pressure conflict occurs. At the level of the 
structure represented by the nervous 
parenchyma – vascular capillary, two types 
of modifications are produced, which may 








connection between them: the stage of a 
cerebral edema, due to water accumulation 
in the parenchyma, and the stage of 
congestive cerebral edematization 
(congestive brain), with an increase in the 
volume of the cerebral parenchyma due to 
vascular dilatation.    
The vascular intracranial hypertension 
occurs in:   
- cerebral illnesses: by affecting the 
venous return and blocking the 
cerebrospinal fluid absorption in cerebral 
venous thromboses, thrombosis of superior 
sagittal sinus, cerebral thrombophlebites, 
mastoiditis (“otitic hydrocephalus”, 
described by Symonds – thrombosis of 
venous sinuses, secondary to oto-
mastoiditis), etc., by slowing down or 
decreasing the venous flow in the superior 
longitudinal sinus in the arterio-venous 
shunt in certain types of intra-cerebral 
vascular malformations, especially Galien 
vein aneurysms, or by decreasing the 
sanguine feeding in cerebral ischemias with 
secondary ischemic cerebral edema, as in 
the ischemic stroke caused by the occlusion 
or stenosis of the big cerebral vessels, with a 
serious form of malign ischemic infarct 
within the territory of the middle cerebral 
artery (massive Sylvian infarct).  
- extra-cerebral illnesses: hypertensive 
encephalopathy with congestive cerebral 
edematization and with extra-cellular 
hydrostatic cerebral edema (by ultra-
filtration); in the cervical or thoracic venous 
blockage.   
The vascular intracranial hypertension 
usually develops only until the occurrence 
of a complete ICH syndrome; but, 
sometimes, it may develop until the 
occurrence of the acute form of ICH due to 
the secondary disorders of the cerebral 
sanguine circulation. In the case of the 
massive ischemic infarct within the 
territory of the middle cerebral artery, the 
cerebral edema occurs quickly, it is 
extensive and the intracranial hypertension 
has an acute evolution, with a mortality of 
up to 80% of the cases.   
4. Idiopathic intracranial hypertension   
This form of ICH has also been 
designated as pseudotumor cerebri, 
essential or cryptogenic ICH, a terminology 
that is outdated. The etiology could not be 
established. It occurs in endocrine illnesses, 
metabolic disorders or various 
hematological illnesses, etc. Not long ago, 
physio-pathological mechanisms were 
thought to include various disorders of the 
cerebrospinal fluid secretion and 
absorption, so that the increase in the ICP 
is secondary to the decrease in the 
cerebrospinal fluid absorption without the 
occurrence of hydrocephaly (this theory is 
also sustained by the efficiency of the 
lumbar-peritoneal shunt). Moreover, the 
cerebral edema could be generated by the 
so-called non-specific “associated factors”, 
which lead to the ICP increase, without the 
possibility of establishing an etiological 
relation.  
The most probable current pathogenic 
hypothesis about the idiopathic intracranial 
hypertension is based on the dynamics of 
the intracranial fluid circuits that allow 
maintaining the auto-regulation of the 
cerebral circulation and of the cerebral 
sanguine flow. In idiopathic ICH, there are 
various pathologic conditions that cause 
progressive damage to the hemato-
encephalic barrier with a hyper-production 
of interstitial fluid and the occurrence of 
the extra-cellular cerebral edema. The 
cerebrospinal fluid is normally produced, 
and the increased pressure from the 








pressure of the cerebrospinal fluid by 
means of increased exchanges from the 
interstitial fluid towards the cerebrospinal 
fluid at the pial trans-cerebral and trans-
ependyma level. The increase in the fluid 
pressure is followed by the increase in the 
resorption of the cerebrospinal fluid and by 
a rapid venous efflux, so that the increased 
intracranial pressure does not affect the 
cerebral circulation, which is maintained 
within the normal limits. The trans-
ependyma and the trans-pial circuit of the 
interstitial fluid towards the cerebrospinal 
fluid represents and efficient compensating 
mechanism when the intracranial pressure 
increases gradually and allows the cerebral 
circulatory auto-regulation.  
Therefore, the idiopathic ICH occurs 
due to the impact on the hemato-
encephalic barrier, by various causes that 
are not established yet, with a hyper-
production of interstitial fluid and an extra-
cellular cerebral edema, with increased 
exchanges from the interstitial fluid towards 
the cerebrospinal fluid at the trans-
ependyma and pial trans-cerebral level; an 
increased resorption of the cerebrospinal 
fluid occurs, and there is a rapid venous 
efflux.  
The idiopathic ICH develops into an 
incomplete ICH syndrome, despite the 
increased ICP values and the presence of 
the papillary edema.  
The causes established for certain forms 
of ICH, which are considered idiopathic, 
will probably include them into one of the 
ICH forms with a known etiology: vascular, 
meningeal or parenchymatous.  
The ICH syndrome may also occur as a 
form of transition between the four forms 
of ICH, or it may be induced by several 
concomitant pathogenic mechanisms of the 
cerebral edema in: bacillary 
meningoencephalitis, neoplasia, hydro-
electrolytic disorders, diabetic keto-acidosis, 
PRES, etc.  
The comparison between the ICH 
forms underlines the existing differences 
very clearly  
The decompensation in parenchymatous 
intracranial hypertension is more rapid and 
it is produced at lower values than the ones 
in idiopathic ICH due to the existence of 
the pressure differences between the 
cranio-spinal compartments and the 
occurrence of the cerebral circulation 
disorders with a decrease in the cerebral 
perfusion pressure in parenchymatous 
ICH.  
The increased critical values of the 
intracranial pressure, the period of ICP 
increase and the duration of the ICP action 
are the main parameters that control the 
intracranial biomechanical fluid stability, 
and which cause the pressure and 
circulatory decompensation. The state of 
clinical instability is produced by the 
passage to more increased values of the 
intracranial pressure, and it occurs when 
the ICP action time is longer than the 
compensation cerebral capacity.  
The pressure-time fluctuation defines 
the pressure increase in relation to the 
action duration of the increased intracranial 
pressure, which induces the auto-regulation 
disorder of the cerebral sanguine 
circulation. The limit decompensation 
conditions occur when the duration of the 
increased ICP action is longer than the 
period corresponding to the same pressure 
values in the pressure compensation 
situation, or the ICP values are higher than 
the ICP values corresponding to the same 
duration of action.  
The evolution of intracranial 
hypertension has three stages and it 
overcomes the critical ICP moments the 








 a. at first, the ICP increase is an alarm 
signal;  
 b. afterwards, the ICP increase exceeds 
the critical value for the occurrence of the 
ICH syndrome; the ICH syndrome evolves 
based on the existing etiology and the 
maintenance of auto-regulation of the 
cerebral sanguine circulation. The 
compensating mechanisms may stop the 
pressure-time fluctuation.  
 c. finally, the acute critical ICP values 
lead to the alteration of the circulatory auto-
regulation, and the compensating 
mechanisms may no longer stop the 
evolution towards the acute stage.  
The first and the second stages are 
reversible, and the third stage corresponds 
to a phase of maximum instability when the 
decompensation with clinical aggravation 
occurs via brainstem ischemia or cerebral 
hernia, which generates irreversible cerebral 
lesions.  
The etiological temporal relation 
classifies the causes of the intracranial 
hypertension into:  
-  acute causes that lead to the acute 
increase in the intracranial pressure and the 
rapid installation of the ICH syndrome, and 
which include the cranial-cerebral 
traumatisms, acute ischemic lesions or 
intra-cerebral hemorrhage; exogenous or 
endogenous intoxications with the rapid 
formation of the cerebral edema, as well as 
infections such as encephalitis or meningitis 
may lead to ICH, too;  
-  chronic causes, which produce the 
progressive increase in the intracranial 
pressure and the belated decompensation of 
the ICH; they include many of the 
intracranial tumors with slow evolution, 
progressive blockage of the cerebrospinal 
fluid circulation, the chronic subdural 
haematoma, the idiopathic intracranial 
hypertension, etc.  
Characteristics of intracranial pressure 
increase   
Intracranial pressure increase is specific 
for every pathogenic mechanism of cerebral 
illnesses, and the ICP monitoring reveals 
characteristic features that establish the 
clinical evolution of the intracranial 
hypertension:  
• the intracranial pressure increasing 
speed to the normal limit values of 20 mm 
Hg and above this value: therefore, there 
are two segments of the ICP increase:  
1. pressure increase segment up to the 
normal limit   
2. pathological pressure increase 
segment, up to the maximum value   
• the maximum pathological value 
reached by the intracranial pressure,  
• duration of the pathological 
intracranial pressure maintenance,  
• the period of recovery to normal 
pressure values   
• the frequency of pressure increase 
reoccurrence or the frequency of 
remissions.   
Several types of pressure increases may 
be described based on the above-mentioned 




Supra-acute intracranial pressure increase; intervals 









1. the supra-acute intracranial pressure 
increase with rapid decompensation.   The 
intracranial pressure increase is very rapid 
up to the value of 20 mm Hg, and 
afterwards to a maximum pressure value. 
This pressure increase occurs in supra-
acute cases of intracranial hematoma, of 
traumatic cerebral edema, or in the 
extending edema of the Sylvian artery 
malign stroke, when a supplementary 
volume is rapidly developed at the 
intracranial level. The infraclinical period is 
very short and the intracranial hypertension 
decompensation is accelerated due to the 
high increasing speed of the supplementary 
intracranial volume and to the exceeding of 
the compensating capacities. Pressure 
increases very rapidly and the pathological 
values of the intracranial pressure are of up 
to 30 - 40 mm Hg. These pathological 
values are maintained for a short while due 




Acute ICP increase, with a prolonged infraclinical 
period and a rapid decompensation; the interval to-t1 
is prolonged, it may last for weeks or even months, 
and the decompensation lasts for a few days 
 
2. acute intracranial pressure increase, 
preceded by a prolonged infraclinical period. 
In these cases, the period when the 
intracranial pressure reaches and exceeds 
the normal pressure values is long, with a 
slow speed of intracranial pressure increase. 
This is the type of intracranial pressure 
increase that occurs in cerebral tumors, 
cerebral abscesses, chronic subdural 
hematomas, etc., usually when the 
occurrence and development of the 
supplementary intracranial volume is slowly 
progressive. During the infraclinical period, 
there is the compensation of the pressure 
increases caused by the newly added 
volume, reaching the limit value. Once the 
compensating capacities have been 
exceeded, the intracranial pressure increase 
is rapid up to the maximum values, which 
are of approximately 30 - 40  mm Hg. The 
period of these pathologic pressure values is 
short due to the rapid decompensation. 
 
 
Figure  3 
Acute ICP increase, with a short infraclinical period, 
and a prolonged period of the decompensation risk; 
the interval to-t1 is short, of a few hours; the interval 
t1-t2 is prolonged 
 
3. the acute increase, with an infraclinical 
period of short duration and a longer period 
of pathological pressure increase. The 
intracranial pressure increase to the normal 
limit of 20 mm Hg is rapid but slower than 
the supra-acute pressure increase. Once the 
normal pressure values have been exceeded, 
the ICP increase is gradual, but at a slower 
speed compared to the previous period. It 
reaches pathological pressure values of 
approximately 30 mm Hg. This occurs in 
hypertensive encephalopathy, which 
includes a self-limiting mechanism: the 
intracranial pressure increase caused by the 








of the cerebral vasodilatation eventually 
lead to the collabation of the intracranial 
sanguine vessel walls, with the decrease to a 
certain degree in the cerebral sanguine 
volume. It is clinically manifested as an 
incomplete or complete intracranial 
hypertension syndrome, which may be 
decompensated unless appropriately 
treated. The period when the pathological 
ICP values are maintained depends on the 
efficiency of the etio-pathogenic therapy of 
the arterial hypertension and on the 
pathogenic therapy of the ICH syndrome. 
 
 
Figure  4 
Slow ICP increase, with a long infraclinical period 
and a prolonged period of pathological pressure 
values 
 
4. the slow intracranial pressure increase 
with a prolonged infraclinical period and a 
long period of pathological ICP increase. 
This type of pressure increase occurs in 
cases of diminished resorption of the 
cerebrospinal fluid in acute meningitis, sub-
arachnoid hemorrhage, cerebral venous 
thromboses and thrombosis of dural 
sinuses, cerebral thrombophlebites, etc. 
Intracranial pressure increases slowly and 
gradually until it reaches the normal limit 
value of 20 mm Hg, and it continues its 
slow increase with periods when it returns 
to normal pressure values, according to the 
etiology of the ICH syndrome. The 
compensating capacity of the pressure 
increase allows a prolonged maintenance of 
the cerebral sanguine flux, and the period of 
the pathological pressure values is rather 
long. There is a development towards a 
prolonged, complete or incomplete ICH 





Chronic ICP increase, with prolonged infraclinical 
period and an extremely long period of pathologic 
pressure values 
 
5. the “chronic”, extremely slow increase 
in intracranial pressure. This occurs in cases 
of idiopathic intracranial hypertension and 
in certain cases of thromboses of 
intracranial venous sinuses. A very slow 
intracranial pressure increase occurs, which 
allows good pressure compensation and the 
maintenance of the cerebral sanguine flux 
to almost normal values. The pathogeny of 
the idiopathic intracranial hypertension 
syndrome is complex, but the intracranial 
pressure increase has a “chronic” aspect. 
The pathogenic ICP values are very high, 
reaching to 60 - 80 mm Hg; these are 
valued that may be maintained in a plate for 
long periods of time. There is a clinical 
evolution towards an incomplete ICH 
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